CLINICAL RESEARCH
Oxygen venous saturation is associated with subclinical myocardial systolic dysfunction in patients with end-stage renal disease undergoing hemodialysis
1
Cardiology Department of General Hospital of Chania, Chania, Greece
2
Nephrology Department of General Hospital of Chania, Chania, Greece
3
Cardiology Department of University Hospital of Heraklion, Heraklion, Greece
Submission date: 2024-03-25
Acceptance date: 2024-04-29
Publication date: 2024-05-27
Corresponding author
Arch Med Sci Atheroscler Dis 2024;9(1):94-101
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The aim of this prospective study was to evaluate the impact of hemodialysis (HD) on myocardial injury, of both right and left ventricle function as well as their association with venous oxygen saturation (ScvO2) alterations.
Material and methods:
We included in the study stable consecutive patients with end-stage renal disease (ESRD) undergoing regular HD. Right and left ventricular speckle-tracking echocardiographies were performed in all patients. The examination calculates the global systolic longitudinal strain (GLS). Blood samples were obtained from the central vein in order to measure the O2 saturation (ScvO2) levels prior and post HD. High sensitive troponin (HST) was also measured in all patients before and after HD.
Results:
Thirty seven patients were evaluated. We found that both mean ScvO2 and left ventricle GLS (LV GLS) were deteriorated after the dialysis session: 76.47 ±1.98 to 71.54 ±5.10, p < 0.05 and –17.73 ±3.44 to –14.21 ±3.44%, p < 0.01, respectively. HST levels were increased at the end of hemodialysis, 22.45 ±13.26 to 106.78 ±146.19 pg/ml, p < 0.01. A significant correlation was also found between the decrease of LV GLS with the ScvO2 reduction, p = 0.001, as well as with the increase of the HST levels, p = 0.001.
Conclusions:
Our data demonstrate that there is a significant worsening of the GLS of the left ventricle at the end of the dialysis, which is strongly associated with the concomitant deterioration of ScvO2. The may be a reliable index of circulatory stress indicating a subclinical myocardial dysfunction during HD.
The aim of this prospective study was to evaluate the impact of hemodialysis (HD) on myocardial injury, of both right and left ventricle function as well as their association with venous oxygen saturation (ScvO2) alterations.
Material and methods:
We included in the study stable consecutive patients with end-stage renal disease (ESRD) undergoing regular HD. Right and left ventricular speckle-tracking echocardiographies were performed in all patients. The examination calculates the global systolic longitudinal strain (GLS). Blood samples were obtained from the central vein in order to measure the O2 saturation (ScvO2) levels prior and post HD. High sensitive troponin (HST) was also measured in all patients before and after HD.
Results:
Thirty seven patients were evaluated. We found that both mean ScvO2 and left ventricle GLS (LV GLS) were deteriorated after the dialysis session: 76.47 ±1.98 to 71.54 ±5.10, p < 0.05 and –17.73 ±3.44 to –14.21 ±3.44%, p < 0.01, respectively. HST levels were increased at the end of hemodialysis, 22.45 ±13.26 to 106.78 ±146.19 pg/ml, p < 0.01. A significant correlation was also found between the decrease of LV GLS with the ScvO2 reduction, p = 0.001, as well as with the increase of the HST levels, p = 0.001.
Conclusions:
Our data demonstrate that there is a significant worsening of the GLS of the left ventricle at the end of the dialysis, which is strongly associated with the concomitant deterioration of ScvO2. The may be a reliable index of circulatory stress indicating a subclinical myocardial dysfunction during HD.
REFERENCES (41)
1.
Kovesdy CP. Epidemiology of chronic kidney disease: an update. Kidney Int Suppl 2022; 12: 7-11.
2.
Jankowski J, Floege J, Fliser D, Böhm M, Marx N. Cardiovascular disease in chronic kidney disease. Circulation 2021; 143: 1157-72.
3.
Sarnak MJ, Amann K, Bangalore S, et al. Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol 2019; 74: 1823-38.
4.
Vallianou N, Mitesh S, Gkogkou A, Geladari E. Chronic kidney disease and cardiovascular disease: is there any relationship? Curr Cardiol Rev 2019; 15: 55-63.
5.
Ikonomidis I, Andreou I, Parissis J, Iliodromitis E. Prognostic significance of global longitudinal strain in chronic kidney disease: the evidence is building. Eur J Heart Fail 2018; 20: 569-71.
6.
Huang SHS, Crowley LE, Jefferies HJ, Eldehni MT, Aghogho O, McIntyre CW. The impact of hemodialysis on segmental and global longitudinal myocardial strain. Can J Cardiol 2014; 30: 1422-8.
7.
Krishnasamy R, Isbel NM, Hawley CM, et al. Left ventricular global longitudinal strain (GLS) is a superior predictor of all-cause and cardiovascular mortality when compared to ejection fraction in advanced chronic kidney disease. PLoS One 2015; 10: e0127044.
8.
Amundsen BH, Helle-Valle T, Edvardsen T, et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll Cardiol 2006; 47: 789-93.
9.
Potter E, Marwick TH. Assessment of left ventricular function by echocardiography: the case for routinely adding global longitudinal strain to ejection fraction. JACC Cardiovasc Imaging 2018; 11: 260-74.
10.
Dandel M, Lehmkuhl H, Knosalla CH, Suramelashvili N, Hetzer R. Strain and strain rate imaging by echocardiography – basic concepts and clinical applicability. Curr Cardiol Rev 2009; 5: 133-48.
11.
Gutierrez G, Wulf-Gutierrez ME, Reines HD. Monitoring oxygen transport and tissue oxygenation. Curr Opin Anaesthesiol 2004; 17: 107-17.
12.
Zhang H, Chan L, Meyring-Wösten A. Association between intradialytic central venous oxygen saturation and ultrafiltration volume in chronic hemodialysis patients. Nephrol Dial Transplant 2018; 33: 1636-42.
13.
Chan L, Zhang H, Meyring-Wosten A, et al. Intradialytic central venous oxygen saturation is associated with clinical outcomes in hemodialysis patients. Sci Rep 2017; 7: 8581.
14.
Zhang H, Campos I, Chan L, Meyring-Wösten A. Association of central venous oxygen saturation variability and mortality in hemodialysis patients. Blood Purif 2019; 47: 246-53.
15.
Canaud B, Kooman JP, Selby NM, et al. Dialysis-induced cardiovascular and multiorgan morbidity. Kidney Int Rep 2020; 5: 1856-69.
16.
Buiten MS, de Bie MK, Rotmans JI, et al. The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients. Heart 2014; 100: 685-90.
17.
Sands JJ, Usvyat LA, Sullivan T, et al. Intradialytic hypotension: frequency, sources of variation and correlation with clinical outcome. Hemodial Int 2014; 18: 415-22.
18.
Ahmadmehrabi S, Tang WHW. Hemodialysis induced cardiovascular disease. Semin Dial 2018; 31: 258-67.
19.
Kooman JP, Katzarski K, van der Sande FM, Leunissen KM, Kotanko P. Hemodialysis: a model for extreme physiology in a vulnerable patient population. Semin Dial 2018; 31: 500-6.
20.
Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol 2009; 4: 914-20.
21.
Poorzand H, Sharifipour F, Kerachian A, et al. Echocardiographic parameters in patients with and without hypotension during dialysis. J Cardiovasc Thorac Res 2021; 13: 228-33.
22.
Kott J, Reichek N, Butler J, Arbei L, Mallipattu SK. Cardiac imaging in dialysis patients. Kidney Med 2020; 2: 629-38.
23.
Bello AK, Okpechi IG, Osman MA, et al. Epidemiology of haemodialysis outcomes. Nat Rev Nephrol 2022; 18: 378-95.
24.
Mitchell C, Rahko PS, Lauwet LA, et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography. J Am Soc Echocardiol 2019; 32: 1-64.
25.
Hensen LC, Goossens K, Delgado V, et al. Prevalence of left ventricular systolic dysfunction in pre-dialysis and dialysis patients with preserved left ventricular ejection fraction. Eur J Heart Fail 2018; 20: 560-8.
26.
McIntyre CW. Effects of hemodialysis on cardiac function. Kidney Int 2009; 76: 371-5.
27.
Aoki J, Ikari Y. Cardiovascular disease in patients with end-stage renal disease on hemodialysis. Ann Vasc Dis 2017; 10: 327-37.
28.
Chiu DY, Green D, Abidin N, Sinha S,, Kalra PA. Cardiac imaging in patients with chronic kidney disease. Nat Rev Nephrol 2015; 11: 207-20.
29.
Liu YW, Su C, Song EJ, et al. The role of echocardiographic study in patients with chronic kidney disease. J Formos Med Assoc 2015; 114: 797-805.
30.
Unger ED, Dubin RF, Deo R, et al. Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction. Eur J Heart Fail 2016; 18: 103-12.
31.
Chen R, Wu X, Shen LJ, et al. Left ventricular myocardial function in hemodialysis and nondialysis uremia patients: a three-dimensional speckle-tracking echocardiography study. PLoS One 2014; 9: e100265.
32.
Green D, Kalra PR, Kalra PA. Echocardiographic abnormalities in dialysis patients with normal ejection fraction. Nephrol Dial Transplant 2012; 27: 4256-9.
33.
Iwahashi N, Horii M, Kirigaya J, et al. Clinical usefulness of the serial examination of three-dimensional global longitudinal strain after the onset of ST-elevation acute myocardial infarction. Circ J 2022; 86: 611-9.
34.
Nemchyna O, Solowjowa N, Dandel M, et al. Predictive value of two-dimensional speckle-tracking echocardiography in patients undergoing surgical ventricular restoration. Front Cardiovasc Med 2022; 9: 824467.
35.
Mora V, Roldan I, Romero E, et al. Comprehensive assessment of left ventricular myocardial function by two-dimensional speckle-tracking echocardiography. Cardiovasc Ultrasound 2018; 16: 16.
36.
Hiebert J, Vacek J, Shah Z, Rahman F, Pierce JD. use of speckle tracking to assess heart failure with preserved ejection fraction. J Cardiol 2019; 74: 397-402.
37.
Harjola VP, Parissis J, Bauersachs J, et al. Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Failure 2020; 22: 1298-314.
38.
Gallet R, Lelouche N, Mitchell-Heggs L. Prognosis value of central venous oxygen saturation in acute decompensated heart failure. Arch Cardiovasc Dis 2012; 105: 5-12.
39.
Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 2013; 382: 339-52.
40.
Ritz E, Wanner C. The challenge of sudden death in dialysis patients. Clin J Am Soc Nephrol 2008; 3: 920-9.
41.
Zhang T, Ling L, Cao SH. Prognostic value of left ventricular global longitudinal strain in chronic kidney disease patients: a systematic review and meta-analysis. Int Urol Nephrol 2020; 52: 1747-56.
Share
RELATED ARTICLE
| ISSN: | 2451-0629 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
